A novel approach to human fertility control: contragestion by the anti-progesterone RU 486.
Baulieu
E E
EE
INSERM U 33, l'Université-Paris-Sud, Lab. Hormones, Bicêtre, France.
D000019:Abortifacient Agents / Q000378:metabolism / Q000627:therapeutic use; D000021:Abortifacient Agents, Steroidal / Q000378:metabolism / Q000627:therapeutic use; D003280:Contraceptives, Oral, Synthetic / Q000378:metabolism / Q000627:therapeutic use; D004963:Estrenes / Q000378:metabolism / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015735:Mifepristone; D011374:Progesterone / Q000037:antagonists & inhibitors*; D011980:Receptors, Progesterone / Q000378:metabolism
D000019:Abortifacient Agents; D000021:Abortifacient Agents, Steroidal; D003280:Contraceptives, Oral, Synthetic; D004963:Estrenes; D011980:Receptors, Progesterone; D015735:Mifepristone; D011374:Progesterone